NLS Pharmaceutics Dividends and Buybacks
Dividend criteria checks 0/6
NLS Pharmaceutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-19.9%
Buyback Yield
| Total Shareholder Yield | -19.9% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
NLS Pharmaceutics gets delisting determination letter from Nasdaq
Oct 05NLS Pharma falls 17% despite positive Phase 2 data for narcolepsy candidate
Sep 27NLS Pharma to get Japanese patent related to Quilience for attention, sleep disorders
Jul 28Here's Why We're A Bit Worried About NLS Pharmaceutics' (NASDAQ:NLSP) Cash Burn Situation
Mar 04
Companies Like NLS Pharmaceutics (NASDAQ:NLSP) Could Be Quite Risky
Nov 12Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if NLSP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NLSP's dividend payments have been increasing.
Dividend Yield vs Market
| NLS Pharmaceutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (NLSP) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (NLSP) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate NLSP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NLSP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate NLSP's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as NLSP has not reported any payouts.